Liberty One Investment Management, LLC Provention Bio, Inc. Transaction History

Liberty One Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 20, 2021	SELL	$6.71 - $11.04 $88,572 - $145,728	-13,200 Closed	0 $0
Q1 2021 Apr 06, 2021	BUY	$10.12 - $19.45 $56,874 - $109,309	5,620 Added 74.14%	13,200 $139,000
Q4 2020 Jan 20, 2021	BUY	$11.79 - $18.94 $24,145 - $38,789	2,048 Added 37.02%	7,580 $128,000
Q3 2020 Nov 03, 2020	BUY	$10.34 - $15.2 $28,062 - $41,252	2,714 Added 96.31%	5,532 $71,000
Q2 2020 Jul 22, 2020	BUY	$7.81 - $17.0 $22,008 - $47,906	2,818 New	2,818 $40,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Liberty One Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty One Investment Management, LLC with notifications on news.